Dermatology

Filter

Nemolizumab in Atopic Dermatitis

3 Mins

March 2025

Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…

Reviewing Non-Scarring Alopecia in Women

Scalp hair is often regarded as a symbol of beauty and vitality across many cultures. Consequently, the loss of hair can significantly…

Dermatitis Artefacta Treatment

Dermatitis artefacta (DA), also known as artefactual skin disease, is a rare psychocutaneous disorder characterised by…

Caregiver Burden, Resilience, and Wellbeing in Cases of SCAR

Severe cutaneous adverse drug reactions (SCAR) are a group of rare but potentially life-threatening conditions that can occur in response…

JAK Inhibitors: A New Frontier in Dermatology

JAK INHIBITORS have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has…

Author Response to: Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’

The aim of our work was to underline that surgery can be applied as a first-line treatment. This was also the shared starting assumption…

Exploring Advancements and Challenges in Adjuvant Melanoma Treatment

Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…

Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’

We agree that the topic of treatment of penile lichen sclerosus in boys is important, and needs more attention in clinical research and…

Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas

Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…

Loading posts...

« Previous 1 2 3 4 5 … 27 Next »